Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus stem cell intraovarian injection versus no treatment for poor ovarian response
IRCT20250609066140N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Aug 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma in infertility and poor ovarian response (POR) (3 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Chemical pregnancy. Started Aug 2025; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20250609066140N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250609066140N1.